Roger Longman of Windhover, an industry consultancy, notes that the total value of biotech acquisitions by pharmaceutical companies has risen dramatically in the past couple of years (see chart).

据Roger Longman称，他所在的业内咨询公司Windhover已经注意到，近几年被制药公司对生物科技公司的收购总值有大幅度的上升。

youdao

Roger Longman of Windhover, an industry consultancy, notes that the total value of biotech acquisitions by pharmaceutical companies has risen dramatically in the past couple of years.

雀鹰商务咨询公司的罗杰·朗曼指出，近几年医药公司收购生物技术国内公司的总额已有迅速上升。

youdao

Rare diseases were long relegated to the backwaters of the drug business, targeted by tiny biotech companies, if at all, and often ignored by drug giants in their search for billion-dollar franchises.

FORBES: Magazine Article

The assertion by a handful of first-world biotech companies of property claims over my body is a repellent reminder of slavery.

ECONOMIST: Letters | The

Thus, these companies seek to broaden their access to innovation by creating networks of academic institutions, research institutes, and biotech companies in order to tap into other sources of intellectual property.

FORBES: Are Non-Profits Getting a Raw Deal From Big Pharma?